Overview
TB-500 corresponds to the actin-binding domain (residues 17-23) of Thymosin Beta-4 (Tb4), a naturally occurring protein found in virtually all nucleated cells. It is among the most studied regenerative peptides, with a substantial body of preclinical research across multiple tissue types.
Key Research Areas
- Actin Polymerisation: Sequesters G-actin, facilitating cytoskeletal remodelling critical for cellular migration during tissue repair.
- Anti-inflammatory Activity: Downregulates pro-inflammatory cytokines (IL-1b, TNF-a) in multiple injury models.
- Angiogenesis: Promotes new capillary formation, studied in cardiac and musculoskeletal injury models.
- Cardiac Research: Investigated in myocardial infarction models for cardiac progenitor cell activation and cardiomyocyte survival.
- Satellite Cell Activation: Research suggests activation of skeletal muscle stem cells, relevant to muscle regeneration models.
Specifications
- Molecular Formula: C212H350N56O78S
- Molecular Weight: 4963.44 g/mol
- CAS: 77591-33-4
- Purity: ≥99% (HPLC verified)
- Form: Lyophilised powder, 10 mg per vial
For in vitro laboratory research use only. Not for human or animal administration.
Reviews
There are no reviews yet.